Practical management of diabetes mellitus

European Journal of Palliative Care

Volumn 13, Issue 6, 2006, Pages 226-229

  McCann, Mary Ann ^a   White, Clare ^a   Au, Simon ^b   Watson, Max ^c,d  

^a Marie Curie Centre   (United Kingdom)

^b Lisburn BT28 1JP   (United Kingdom)

^c NORTHERN IRELAND HOSPICE   (United Kingdom)

^d BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37849185953     PISSN: 13522779     EISSN: 14790793     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Gale EAM, Anderson JV. Diabetes mellitus and other disorders of metabolism. In: Kumar P, Clarke M (eds). Clinical Medicine, 4th edn. Edinburgh: WB Saunders, 1998.
2. Wang J, Armour T, Geiss LS, Engelgau MM. Obesity and diabetes: dual epidemics on the rise. Current Opinion in Endocrinology and Diabetes 2005; 12(2): 174-180.
3. McCoubrie R, Jeffrey D, Paton C, Dawes L. Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines. Eur J Cancer Care 2005; 14(3): 244-248.
4. Laakso M. Benefits of strict glucose and blood pressure control in type 2 diabetes: lessons from the UK prospective diabetes study. Circulation 1999; 99(4): 461-462.
5. Lasker R. The diabetes control and complications trial. Implications for policy and practice. New Engl J Med 1993; 329(14): 1035-1036.
6. Cheng AYY, Fantus IG. Oral antihyperglycemic therapy for type 2 diabetes mellitus. Can Med Assoc J 2005; 172(2): 213-266.
7. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-553.
8. British National Formulary 2006; 51.
9. Rosiglitazone (Avandia): new (and improved?) insulin sensitizer. Am J Nurs 1999; 99(9): 24BBB, 24DDD.
10. Plank J, Bodenlenz M, Sinner F et al. A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir. Diabetes Care 2005; 28(5): 1107-1112.
11. Hirsch IB. Insulin analogues. New Engl J Med 2005; 352(2): 174-183.
12. Ahmed Z, Lockhart CH, Weiner M, Klingensmith G. Advances in diabetic management: implications for anesthesia. Anesth Analg 2005; 100(3): 666-669.
13. Walsh LJ, Wong CA, Oborne J et al. Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax 2001; 56: 279-284.
14. Hardy JR, Rees E, Ling J et al. A prospective survey of the use of dexamethasone on a palliative care unit. Palliat Med 2001; 15(1): 3-8.